

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
TTM vs. 5-year historical average (annual ratios)
| Metric | CLX | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 17.9x | 53.4x · sector 38.2x | Discount |
| Forward P/E (FY27E) | 15.2x | EPS est. 5.69 | Discount |
| Price / Book | 116.9x | 69.3x | Elevated |
| Price / Sales | 1.6x | 2.3x | Discount |
| EV / EBITDA | 13.5x | 23.0x | Discount |
| Return on equity | -1893.5% | — | Weak |
| Gross margin | 42.3% | 41.1% | In line |
| Debt / Equity | 61.33 | 19.61 | Levered |
| Piotroski / Altman Z | 5/9 | Z 2.03 | Grey zone |
Discounted cash flow model
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 50.33 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 75.59 | Oscillator | Neutral |
| Williams %R (14) | -33.00 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.41 (Hist 0.87) | Oscillator | Buy |
| Average Directional Index (14) | 24.19 (+DI 22.7 / -DI 19.0) | Trend |
| EMA 20 | 85.69 | MA | Buy |
| SMA 20 | 84.00 | MA | Buy |
| EMA 50 | 88.80 | MA | Sell |
| SMA 50 | 90.47 | MA | Strong Sell |
| SMA 200 | 100.27 | MA | Strong Sell |
Current price $86.40
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 19, 26 | JP Morgan | maintain | Underweight | Underweight |
| Oct 16, 26 | Barclays | maintain | Underweight | Underweight |
| Oct 15, 26 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Oct 14, 26 | Citigroup | maintain | Neutral | Neutral |
| Oct 13, 26 | TD Cowen | maintain | Hold | Hold |
| Oct 5, 26 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Sep 11, 26 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Sep 11, 26 | Citigroup | maintain | Neutral | Neutral |
| Aug 4, 26 | UBS | maintain | Neutral | Neutral |
Stock news · updated daily
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies that changed their dividends. Companies with upcoming ex-dividend dates.
I rank all 69 S&P 500 Dividend Aristocrats by my 9F Quality Scores, segmenting them into undervalued, fairly valued, and overvalued groups. My consensus fair value estimates, blending up to 40 data points per stock, highlight 12 undervalued and 18 fairly valued Aristocrats, with 39 currently overvalued. Investment candidates vary by style: ADP, BRO, and NDSN for growth; NEE for total return; PEP and O for income; CAT and GWW for past performance.
Carnegie Investment Counsel raised its position in The Clorox Company (NYSE: CLX) by 242.6% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 11,821 shares of the company's stock after buying an additional 8,371 shares during the period. Carnegie Investment
Both Kimberly-Clark and Clorox are mid-overhaul, both pay yields above 4.5%, and both have dividend payout ratios that leave almost no cushion.
If you are looking for reliable high-yield dividend stocks, the out-of-favor consumer staples sector is full of them.
Clorox's nearly 6% yield towers over Colgate's modest payout, making it look like a retiree's dream income stock.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Every month, we screen for dividend growth stocks that have relatively higher yields. While higher yields can often mean relatively higher risk, depending on the sector, we also include consistency and safety dividend quant grades in the process. We then take a quick look at the top 5 that come up in the screening to see if they are potentially worth pursuing for deeper research and due diligence.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 3, 2026 | 1.64 | 1.66 | Beat 1.2% | $1.95B |
| Apr 30, 2026 | 1.55 | 1.64 | Beat 5.8% | $1.67B |
| Feb 3, 2026 | 1.43 | 1.39 | Miss -2.8% | $1.67B |
| Nov 3, 2025 | 0.82 | 0.85 | Beat 3.9% | $1.43B |
| Jul 31, 2025 | 2.20 | 2.87 | Beat 30.5% | $1.99B |
| May 5, 2025 | 1.55 | 1.45 | Miss -6.5% | $1.67B |
FY2026 · 10-K disclosure
FY2026 · 10-K disclosure
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 5, 26 | Rendle Linda J | director, officer: Chief Executive Officer | A-Award | 29,352 @ $80.41 | $2.36M |
| Oct 5, 26 | Rendle Linda J | director, officer: Chief Executive Officer | F-InKind | 692 @ $80.41 | $55.64K |
| Oct 5, 26 | Rendle Linda J | director, officer: Chief Executive Officer | F-InKind | 11,989 @ $80.41 | $964.0K |
| Oct 5, 26 | Peck Laurene E | officer: VP - CAO & Corp Controller | A-Award | 1,172 @ $80.41 | $94.24K |
| Oct 5, 26 | Peck Laurene E | officer: VP - CAO & Corp Controller | F-InKind | 30 @ $80.41 | $2.41K |
| Oct 5, 26 | Peck Laurene E | officer: VP - CAO & Corp Controller | F-InKind | 339 @ $80.41 | $27.26K |
| Oct 5, 26 | Marriner Kirsten | officer: EVP - Chief Admin Officer | A-Award | 6,637 @ $80.41 | $533.7K |
| Oct 5, 26 | Marriner Kirsten | officer: EVP - Chief Admin Officer | F-InKind | 1,951 @ $80.41 | $156.9K |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Oct 7, 2026 | 2026-10-07 16:24:05 | View |
| 4 | Oct 7, 2026 | 2026-10-07 16:24:04 | View |
| 4 | Oct 7, 2026 | 2026-10-07 16:24:02 | View |
| 4 | Oct 7, 2026 | 2026-10-07 16:24:01 | View |
| 4 | Oct 7, 2026 | 2026-10-07 16:23:59 | View |
| 4 | Oct 7, 2026 | 2026-10-07 16:23:57 | View |
| 4 | Oct 7, 2026 | 2026-10-07 16:23:56 | View |
| ARS | Oct 7, 2026 | 2026-10-07 16:17:36 | View |
| DEFA14A | Oct 7, 2026 | 2026-10-07 16:16:41 | View |
| DEF 14A | Oct 7, 2026 | 2026-10-07 16:15:40 | View |
Proxy statement (DEF 14A) disclosures